---
title: "AE_ALPELISIB"
date: "2023-12-01 17:01:03"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ±ä¾†è‡ª: [[adverse event-of-snippets]]

# AE_ALPELISIB

**Adverse effects such as hyperglycemia (~60%), diarrhea (~50%), nausea (44%), anorexia, skin rash (35%), vomiting (27%), stomatitis (24%), fatigue, alopeia (~20%), mucositis, pruritis, headache, and arthralgia.
AEAXITINIB
**AEs such as diarrhea, hypertension, fatigue, anorexia, nausea, loss of vice, HFS, weight loss, and vomiting, less AEs such as hematuria (3%), tinnitus (3%), lipase increased (3%), rectal hemorrhage (2%), hemoptysis (2%), DVT (1%), and TIA (1%)

### Siblings

- [[AE_ABVD]]
- [[AE_ACT]]
- [[AE_ALECTINIB]]
- [[AE_ALIMTA]]
- [[AE_ALPELISIB]]
- [[AE_BENDAMUSTINE]]
- [[AE_CCRT]]
- [[AE_CDK46]]
- [[AE_CRIZOINIB]]
- [[AE_DABRAFENIB]]
- [[AE_ENHERTU]]
- [[AE_ERIBULIN]]
- [[AE_FOLFOX]]
- [[AE_GLIVEC]]
- [[AE_HERCEPTIN]]
- [[AE_LANREOTIDE]]
- [[AE_LAPATINIB]]
- [[AE_LAR]]
- [[AE_LETROZOLE]]
- [[AE_OLAPARIB]]
- [[AE_OSIMERTINIB]]
- [[AE_PAZOPANIB]]
- [[AE_PEMIGATINIB]]
- [[AE_PERTUZUMAB]]
- [[AE_RAMUCIRUMAB]]
- [[AE_RECTAL]]
- [[AE_REGORAFENIB]]
- [[AE_SORAFENIB]]
- [[AE_SUNITINIB]]
- [[AE_TAS102]]
- [[AE_TAXOTERECDDP]]
- [[AE_TOPOTECAN]]
- [[AE_UFT]]
- [[AE_VEMURAFENIB]]
- [[AE_VINORELBINE]]
- [[AE_XELOX]]

